Literature DB >> 5469762

Anaplastic teratoid carcinoma of the mediastinum, pericardium and lung. An example of successful cooperative management.

L L Alexander, M C Li, J W Cordice, E C Reid, R G Howard.   

Abstract

Entities:  

Mesh:

Year:  1970        PMID: 5469762      PMCID: PMC2611846     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  8 in total

1.  The effect of actinomycin D on cancer in childhood.

Authors:  C T TAN; H W DARGEON; J H BURCHENAL
Journal:  Pediatrics       Date:  1959-10       Impact factor: 7.124

2.  The chemotherapeutic effects and complications of actinomycin D in patients with advanced cancer.

Authors:  G E MOORE; J A DIPAOLO; T KONDO
Journal:  Cancer       Date:  1958 Nov-Dec       Impact factor: 6.860

3.  Effects of combined drug therapy on metastatic cancer of the testis.

Authors:  M C LI; W F WHITMORE; R GOLBEY; H GRABSTALD
Journal:  JAMA       Date:  1960-11-05       Impact factor: 56.272

4.  Potentiation of x-ray effects by actinomycin D.

Authors:  G J D'ANGIO; S FARBER; C L MADDOCK
Journal:  Radiology       Date:  1959-08       Impact factor: 11.105

5.  Modification of the radiation response determined by single-cell technics: actinomycin D.

Authors:  R E BASES
Journal:  Cancer Res       Date:  1959-12       Impact factor: 12.701

6.  The effect of combined irradiation and chemotherapy on cancer growth with special reference to studies with folic acid analogues.

Authors:  M K LOKEN; Y S KIM; D G MOSSER; J F MARVIN
Journal:  Radiology       Date:  1959-08       Impact factor: 11.105

7.  Combination therapy of malignant tumors with ionizing radiations and chemicals; a review.

Authors:  H N BANE; J T CONRAD; G S TARNOWSKI
Journal:  Cancer Res       Date:  1957-07       Impact factor: 12.701

8.  Advances in chemotherapy of cancer in man.

Authors:  S FARBER; D PINKEL; E M SEARS; R TOCH
Journal:  Adv Cancer Res       Date:  1956       Impact factor: 6.242

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.